Treatment with G6PD inhibitor effectively reduced G6PD expression in lung cancer cells and substantially inhibited the proliferation ability of lung cancer cells, which showed the first time of the adverse prognostic significance and pro-carcinogenesis effect of G6PD in LUAD. The gene discussed is G6PD; the disease is lung carcinoma.